Assertion Supported AI assessment confidence: 100% certainty 5/5 debate potential 1/5

Hirsch: GoodRx spends hundreds of millions of dollars on marketing

Doug Hirsch · Two-Sided Networks in Healthcare - a Founder's Playbook · Jul 27, 2022 · at 16:37

Doug Hirsch, co-founder of GoodRx, details the scale of marketing spend at GoodRx despite emphasizing organic growth.

0:00 / 0:02exact quote · 2.0s

▶ Watch the full episode on YouTube → 720p mp4 · rendered on demand · StarZero watermark

“We spend hundreds of millions of dollars in marketing”

quote is from the automated transcript, cleaned for reading: filler sounds and stutters are removed, nothing is rephrased. names can be misheard (the analysis reads context, assessments check outside sources). how →

The claim, plainly

GoodRx spends hundreds of millions of dollars on marketing.

a quote alone can be ambiguous, so this restates it with the references and context of the conversation around it resolved. AI-written; the tape below the player is the source.

Assessment

The resolution criteria require GoodRx SEC Form 10-K filings for fiscal year 2022 or 2023 to report annual sales and marketing expenses of at least $100 million. According to GoodRx Holdings, Inc. Form 10-K filings, GAAP Sales and Marketing expenses were $357,631,000 for FY 2022 and $341,328,000 for FY 2023 (and Non-GAAP Adjusted Sales and Marketing expenses exceeded $300 million in both years). Both metrics significantly exceed the $100 million threshold.

FY 2022 Form 10-K reported GAAP Sales and Marketing Expense of $357,631,000.
FY 2023 Form 10-K reported GAAP Sales and Marketing Expense of $341,328,000.

Checked against

[1] goodrx.com [2] fool.com [3] goodrx.com [4] goodrx.com [5] financialcontent.com [6] goodrx.com [7] businesswire.com [8] sec.gov

"Sales and marketing" "GoodRx Holdings, Inc." "Consolidated Statements of Operations" "2023" "2022" "Sales and marketing" "GoodRx" "357,631" OR "357,6" GoodRx SEC Form 10 K fiscal year 2022 sales and marketing expense "Sales and marketing" "GoodRx" "Year Ended December 31," "2022" "2021" "Sales and marketing" "GoodRx Holdings, Inc." "2022" "Consolidated Statements of Operations" "in thousands" GoodRx 2023 10 K sales and marketing expense "Sales and marketing" "341,328" "GoodRx" GoodRx 10-K 2022 "Sales and marketing" "Year Ended December 31, 2022" "341,328" "GoodRx" "Consolidated Statements of Operations" site:sec.gov "GoodRx Holdings, Inc." "FORM 10-K" "Sales and marketing" "December 31, 2023"

assessed as of 2026-07-28

This assessment is an AI reading of a public statement, made against the cited references with the confidence shown. It can be wrong. The quote, the tape and the references are all on this page; if something is off, use report an error below. full disclaimer →

Mentioned

GoodRx

⚑ Spot an error? Report it

More from Doug Hirsch

Insight

Hirsch: Healthcare platforms must optimize for outcomes, not time spent

“Remember I came from the world of social. Like I was at Facebook and Yahoo where time spent was like the God metric. It was like, oh my God, we just care about as many eyeballs and as much time as we can. And it could actually, it's less about time spent. It's…”

Doug Hirsch Jul 27, 2022 ▶ 25:52 Two-Sided Networks in Healthcare - a Founder's Playbook

Disclosure

Hirsch: GoodRx features 24/7 live nurse chat on drug pages

“We have a program right now where we actually have a nurse, a live, 24 seven nurse chat sitting on a drug page. So you can actually talk to a nurse about the drug.”

Doug Hirsch Jul 27, 2022 ▶ 28:36 Two-Sided Networks in Healthcare - a Founder's Playbook

Hirsch: GoodRx spends hundreds of millions of dollars on marketing

More from Doug Hirsch

Turn any episode into a week of clips.